Redx About us Our pipeline Our science Investors News & events Contact us Expert Advisers Aurélien Marabelle MD, PhD Clinical Director of Cancer Immunotherapy Gustave Roussy Institute Dr. Florian Rieder Clinical Investigator Cleveland Clinic Dr. Gisli Jenkins Professor of Thoracic Medicine National Heart and Lung Institute, Imperial College London RXC004 clinical investigators Read more about our clinical investigators Redx Copyright © 2021 Redx Pharma Plc Privacy & terms Cookie policy Website design & build by Carr Kamasa Design We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies. Cookie Policy. I Accept

Redx About us Our pipeline Our science Investors News & events Contact us Our scientific publications Filter by Programme All Programme Key External Link PDF AACR 2021 Poster – Mechanism of action of RXC004, a Wnt pathway inhibitor, in genetically-defined models of cancer RXC004 ELRIG 2020 Poster – Validation of immune cell analysis in whole blood by flow cytometry for clinical biomarker investigation RXC004 AACR 2019 – Efficacy of the Wnt/Beta-Catenin pathway inhibitor RXC004 in genetically-defined models of cancer RXC004 AACR 2019 – Wnt/b-Catenin pathway inhibitor RXC004 enhances the immunity of pre-clinical models of cancer RXC004 ERS 2019 Poster – Pre-clinical data using candidate compound RXC006 demonstrates that porcupine is a novel and promising target for the treatment of IPF RXC006 Previous Page 1 of 4 Next 1 2 3 4 About us Presentations, analyst reports, documents & videos News & events Redx Copyright © 2021 Redx Pharma Plc Privacy & terms Cookie policy Website design & build by Carr Kamasa Design We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies. Cookie Policy. I Accept